Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126227071 | 12622707 | 1 | I | 20160802 | 20160804 | 20160804 | EXP | CH-JNJFOC-20160801492 | JANSSEN | HOFER S, KESSLER M, GODAU J, WEILER D, FRONTZEK K, RUSHING EJ, ET AL. INTRAVASCULAR LARGE B-CELL LYMPHOMA: A RARE AND POTENTIALLY REVERSIBLE CAUSE OF CEREBRAL STROKE. MEMO - MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY 01-JUN-2016;9 (2):59-62. | 57.00 | YR | A | M | Y | 0.00000 | 20160804 | MD | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126227071 | 12622707 | 1 | PS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | U | U | 50718 | LIPOSOME INJECTION | ||||||||
| 126227071 | 12622707 | 2 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 126227071 | 12622707 | 3 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 126227071 | 12622707 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 126227071 | 12622707 | 5 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 126227071 | 12622707 | 6 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 3.5 G/M2 | U | 0 | UNSPECIFIED | ||||||||
| 126227071 | 12622707 | 7 | SS | CARMUSTINE | CARMUSTINE | 1 | Unknown | 400 MG/M2 | U | 0 | 400 | MG/M**2 | UNSPECIFIED | ||||||
| 126227071 | 12622707 | 8 | SS | THIOTEPA. | THIOTEPA | 1 | Unknown | U | 0 | 5 | MG/KG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126227071 | 12622707 | 1 | Diffuse large B-cell lymphoma |
| 126227071 | 12622707 | 2 | Diffuse large B-cell lymphoma |
| 126227071 | 12622707 | 3 | Diffuse large B-cell lymphoma |
| 126227071 | 12622707 | 4 | Diffuse large B-cell lymphoma |
| 126227071 | 12622707 | 5 | Diffuse large B-cell lymphoma |
| 126227071 | 12622707 | 6 | Diffuse large B-cell lymphoma |
| 126227071 | 12622707 | 7 | Diffuse large B-cell lymphoma |
| 126227071 | 12622707 | 8 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126227071 | 12622707 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126227071 | 12622707 | Febrile neutropenia | |
| 126227071 | 12622707 | Off label use | |
| 126227071 | 12622707 | Pneumocystis jirovecii pneumonia | |
| 126227071 | 12622707 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |